摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-guanidinopropoxy)-N-(6-phenoxybenzothiazol-2-yl)benzamide | 1163857-84-8

中文名称
——
中文别名
——
英文名称
2-(3-guanidinopropoxy)-N-(6-phenoxybenzothiazol-2-yl)benzamide
英文别名
2-(3-Guanidino-propoxy)-N-(6-phenoxy-benzothiazol-2-yl)-benzamide;2-[3-(diaminomethylideneamino)propoxy]-N-(6-phenoxy-1,3-benzothiazol-2-yl)benzamide
2-(3-guanidinopropoxy)-N-(6-phenoxybenzothiazol-2-yl)benzamide化学式
CAS
1163857-84-8
化学式
C24H23N5O3S
mdl
——
分子量
461.544
InChiKey
QBIFLSAZDLIDGI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    33
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    153
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    2-(3-[N',N''-bis(carbamic acid tert-butyl ester)]guanidinopropoxy)-N-(6-phenoxybenzothiazol-2-yl)benzamide 在 盐酸 作用下, 以 乙酸乙酯 为溶剂, 以53%的产率得到2-(3-guanidinopropoxy)-N-(6-phenoxybenzothiazol-2-yl)benzamide
    参考文献:
    名称:
    Low molecular weight non-peptide mimics of ω-conotoxin GVIA
    摘要:
    We report the synthesis and biological activity of a low molecular weight non-peptidic mimic of the analgesic peptide omega-conotoxin GVIA. The molecular weight of this compound presents a reduction by 193 g/mol compared to a previously reported lead. This compound exhibits an EC50 of 5.8 mu M and is accessible in only six synthetic steps compared to the original lead (13 steps). We also report several improvements to the original synthetic route. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.03.130
点击查看最新优质反应信息

文献信息

  • Low molecular weight non-peptide mimics of ω-conotoxin GVIA
    作者:Peter J. Duggan、Richard J. Lewis、Y. Phei Lok、Natalie G. Lumsden、Kellie L. Tuck、Aijun Yang
    DOI:10.1016/j.bmcl.2009.03.130
    日期:2009.5
    We report the synthesis and biological activity of a low molecular weight non-peptidic mimic of the analgesic peptide omega-conotoxin GVIA. The molecular weight of this compound presents a reduction by 193 g/mol compared to a previously reported lead. This compound exhibits an EC50 of 5.8 mu M and is accessible in only six synthetic steps compared to the original lead (13 steps). We also report several improvements to the original synthetic route. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
查看更多